Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis

Proton pump inhibitors, PPIs, are widely prescribed and sold globally. Although initially intended for time-limited treatment of acute disorders, such as gastric ulcers and esophagitis, PPIs are now commonly used for prolonged durations and are considered safe for over the counter access. Recent stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Makunts, Tigran, Cohen, Isaac V., Awdishu, Linda, Abagyan, Ruben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381091/
https://www.ncbi.nlm.nih.gov/pubmed/30783195
http://dx.doi.org/10.1038/s41598-019-39335-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381091/
https://www.ncbi.nlm.nih.gov/pubmed/30783195
http://dx.doi.org/10.1038/s41598-019-39335-7

Ejemplares similares